In the field of research the Faculty of Health, Medicine en Life Sciences (FHML) cooperates closely with several national and international organisations. All FHML schools participate in national research schools. Moreover, FHML participates in several Leading Technology Institutes.
Also in the field of education FHML collaborates on an international level, e.g. with the World Health Organization (WHO).
Participation in national research schools
Research schools are centres of high-quality research with structural attention to the study programmes of young researchers. If research schools meet the quality criteria for education, organisation, finances, scientific programme and (inter) national collaboration, then the Research School Accreditation Committee (ECOS) of The Royal Netherlands Academy of Arts and Sciences may grant the research school an accreditation for a six-year period.
All schools of FHML participate in national research schools. Some schools are even the secretary of a national research school. FHML is the secretary of the following national research schools:
FHML also participates in the:
TMC Netherlands Graduate Research School of Science, Technology and Modern Culture
Participation in Leading Technology Institutes
The academic research of the faculty and Maastricht UMC+ competes with that of different University Medical Centres in the Netherlands. Especially in the funding of research this competition shows. Government policy is increasingly focused on competition in terms of quality of research and researchers. This is not only the case for state-financed research but also for public-private research funding. To this end, the Leading Technology Institutes (LTI) were established in the Netherlands. Maastricht UMC+ participates in five of these LTI (biomedical materials, molecular medicine, pharmaceuticals, nutrition and polymers).
Through long term strategic alliances between business and knowledge centres Leading Technology Institutes enable the rapid innovation of processes and products. LTI conduct research programmes to develop knowledge on a speific theme of international interest. In these studies fundamental and strategic questions from business are answered.
Parelsnoer Clinical Biobanks
The Maastricht University Medical Centre participates in Parelsnoer Clinical Biobanks. Parelsnoer was established by the Netherlands Federation of University Medical Centres (NFU), a unique partnership between the eight university medical centres (teaching hospitals) in the Netherlands. As from 2020 Parelsnoer is part of Health-RI.
The Parelsnoer Clinical Biobanks host clinical data, human biomaterial and/or images of carefully documented patients suffering from 19 closely defined clinical conditions, ranging from inflammatory, cardiovascular and neurological conditions, malignancies to rare disorders. These are collected and stored locally in the UMCs in a uniform manner. In certain cases, data are collected in collaboration with general hospitals. Together, the data collections form a federated infrastructure, a large cohort enabling broader scientific research. Parelsnoer offers researchers an infrastructure and and standard procedures for the establishment, expansion and optimisation of clinical biobanks for scientific research. It hereby ensures that scientific research is connected with high quality health care in a natural manner, which enables easy and reliable patient research and supports the development of scientific knowledge and innovative methods of treatment to improve health care or even prevent the disease in the future. To ensure patient privacy clinical data is encrypted.
For more information visit the Parelsnoer website (in Dutch)
Dr. Dorine Collijn
Maastricht UMC+ in India
In 2008 Maastricht UMC+ started to explore the possibilities for research collaboration with Indian institutes. The importance of cooperation with Indian institutes in the field of research for Maastricht UMC+ is twofold. First of all, India is a source of talent. Secondly, the enormous population offers opportunities to perform clinical and population based research that in the Netherlands are only possible with much effort and patience. Since the main disease research areas of Maastricht UMC+ are also important for India, cooperation often leads to a win-win situation: combination of our knowledge and technological infrastructure with the Indian population and research talent helps us as well as our Indian partners.
visit the Maastricht UMC+ in India website